Skip to main content
. 2005 May 31;92(12):2107–2113. doi: 10.1038/sj.bjc.6602624

Table 5. Summary data from the testis tumour module.

Testicular tumour module Pretreatment End of treatment 6 Months posttreatment 12 Months posttreatment 24 Months posttreatment
Have you: % of patients reporting ‘quite a bit’ or ‘very much’a
 … lost any hair? 3% 59% 10% 0% 7%
 If yes, been upset by your hair loss? 0% 17% 33% 0% 14%
 … had pain, numbness of tingling in your hands and/or feet? 0 3% 37% 24% 13% 12%
 … had pale/cold fingers/toes? 0% 15% 12% 7% 7%
 … had ringing in the ears? 3% 37% 10% 7% 2%
 … had difficulty hearing? 3% 5% 2% 7% 5%
 … felt less masculine as a result of your disease or treatment? 5% 15% 7% 7% 5%
 … had dry ejaculation during intercourse? 5% 3% 3% 0% 3%
 … been interested in sex? 64% 27% 71% 78% 80%b
 … had difficulty in getting an erection? 5% 15% 2% 13% 5%
 … had difficulty in keeping an erection 8% 15% 5% 10% 8%
 … had problems with the intensity of your orgasm? 5% 8% 5% 8% 5%
 … been sexually active? 41% 20% 54% 54% 58%
 If yes, enjoyed sex? 83% 72% 92% 84% 86%
 …been worried abut the possibility of being unable to father a child? 18% 13% 7%b 10% 2%
 … had a satisfying partner relationship? 89% 81% 95% 91% 89%
 … feared recurrence of the disease? 32% 37% 29% 18% 20%
 … felt that the right treatment decisions were made ? 97% 95% 100% 92% 98%
 … felt satisfied with your clinic visits? 90% 95% 93% 97% 90%
 … been limited in your hobbies or other leisure pursuits? 31% 51% 7% 3%b 2%b
a

Cells shaded black indicate that a formal comparison with baseline levels was significantly different at the P<0.001 level; cells shaded in grey indicate differences at the level 0.001<P<0.01.

b

Indicates an improvement relative to baseline.